We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Gene Related to Abnormal Brain Development Identified

By LabMedica International staff writers
Posted on 13 Sep 2017
Using integrative genomics of brain cells, researchers have identified a gene thought to be associated with the types of brain damage that can be caused by inflammation during premature birth, suggesting the presence of a previously unknown mechanism of brain injury.

Premature labor is associated with inflammation in the mother or baby, often due to infection. More...
This can cause damage to the brain that could lead to lifelong conditions (e.g. cerebral palsy, autism or other learning or behavioral difficulties) in up to 30% of pre-term babies. The new study, a collaboration between researchers at King’s College London (London, UK), Inserm (Paris, France) and Paris Diderot University, and Duke-NUS Medical School (Singapore), investigated the role of microglial cells, which control the immune response in the brain, in responding to this inflammation. The research team found a gene, DLG4, expressed in these cells that are thought to be involved in controlling the inflammatory process.

DLG4 is found in different forms in all humans but previously was thought only to play a role in the function of the nervous system. The new finding suggests it is also involved in the process resulting in brain damage in some preterm babies. The study used an integrative approach that included mouse models of inflammation and a genomic analysis of over 500 infant brain scans. It identified differences in the way DLG4 was expressed in microglia in both the mouse models and brain scans.

Whilst the association requires further study to confirm the role of microglia and the DLG4 gene, the result contributes to an existing body of evidence that links the gene with both the immune response and neuropsychiatric diseases such as schizophrenia and autism.

“We have shown that the DLG4 gene is expressed differently in microglia when a brain has been damaged by inflammation,” said David Edwards, professor at King’s College London. Enrico Petretto, associate professor from Duke-NUS Medical School said: “Given the previously acknowledged role of the DLG4 gene in brain diseases such as autism and schizophrenia, our study strengthens the link between the immune response and susceptibility to develop these brain disorders.” Professor Pierre Gressens from Inserm-Paris Diderot University and King’s College London said: “This study identifies for the first time the microglial expression of DLG4, a gene previously considered as expressed in neurons only and highlights the potential role of microglia in different neurodevelopmental disorders.”

The researchers hope to provide a new avenue to study and understand how this inflammation and subsequent brain damage is caused so that measures can be taken and treatments developed to stop or even prevent the inflammation associated with pre-term birth. Identifying effects of mutations in DLG4 may also be useful for diagnostics.

The study, by Krishnan ML et al, was published September 5, 2017, in the journal Nature Communications.

Related Links:
King’s College London
Inserm
Duke-NUS Medical School

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.